Lupin receives USFDA approval for generic Percocet Tablets

28 Feb 2017 Evaluate

Lupin has received final approval for its Oxycodone and Acetaminophen Tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Vintage Pharmaceuticals LLC’s Percocet Tablets, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg. the company shall commence promoting the product shortly. Percocet Tablets had US sales of $838.7 million, as per IMS MAT December 2016.

Lupin’s Oxycodone and Acetaminophen Tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg is the AA rated generic equivalent of Vintage Pharmaceuticals LLC’s Percocet Tablets, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg. Oxycodone and Acetaminophen Tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg are indicated for relief of moderate to moderately severe pain.

Lupin is a pharmaceutical company and is engaged in formulation of drugs and active pharmaceutical ingredients (APIs), generics, biotechnology, novel drug discovery and development, drug delivery systems and specialty pharmaceuticals.



Lupin Share Price

1616.90 6.35 (0.39%)
08-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6050.00
Cipla 1383.40
Zydus Lifesciences 1006.10
Lupin 1616.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.